top of page

Molnupiravir: a promising new treatment for COVID-19

Writer's picture: Ed EwingEd Ewing

Early studies show molnupiravir to be the first oral medication effective against SARS-CoV-2. Safe at therapeutic levels, its active intracellular form introduces lethal mutations in the virus but does not mutate host cell DNA. Developed at Emory University and marketed by Merck, it is most effective when given early in infection. Wikipedia offers an excellent new summary at https://en.wikipedia.org/wiki/Molnupiravir . If further studies confirm the value of molnupiravir, this will be a valuable addition to the fight against COVID-19. However, the best course remains for all of us and our loved ones to get vaccinated, minimizing our chances to get infected or sick with COVID-19 in the first place.

10 views0 comments

Recent Posts

See All

Return to the Fold

So glad to be back at GMG after too much time away. Such a warm welcome and a beautiful and varied program. A special welcome to new...

The Chopin Podcast

Baen Laude, in partnership with the Chopin Foundation of the United States, is producing a series of podcasts leading up to the 11th...

Comments


bottom of page